Spruce Biosciences Free Cash Flow (FCF) History (SPRB)
Spruce Biosciences reported −$56.0M in free cash flow for fiscal 2024, a decrease of $22.7M from the previous fiscal year, with a free cash flow margin of −1139.56%.
View full Spruce Biosciences company overviewSpruce Biosciences free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2024 | 2024-12-31 | −$56.0M | −$22.7M | — | −1139.56% |
| 2023 | 2023-12-31 | −$33.3M | $8.4M | — | −329.88% |
| 2022 | 2022-12-31 | −$41.7M | −$5.7M | — | — |
| 2021 | 2021-12-31 | −$36.0M | −$8.4M | — | — |
| 2020 | 2020-12-31 | −$27.6M | −$15.0M | — | — |
| 2019 | 2019-12-31 | −$12.6M | — | — | — |
Spruce Biosciences quarterly free cash flow
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$22.3M | −$10.0M | — | — |
| Q1 2026 | 2026-03-31 | −$8.7M | −$162,000 | — | — |
| Q2 2025 | 2025-06-30 | −$8.8M | $977,000 | — | — |
| Q1 2025 | 2025-03-31 | −$12.7M | −$5.1M | — | — |
| Q3 2023 | 2023-09-30 | −$12.3M | −$2.6M | — | −399.48% |
| Q3 2022 | 2022-09-30 | −$8.6M | $226,000 | — | — |
| Q4 2021 | 2021-12-31 | −$9.8M | −$2.2M | — | — |
| Q3 2021 | 2021-09-30 | −$7.7M | — | — | — |
| Q2 2021 | 2021-06-30 | −$9.7M | — | — | — |
| Q1 2021 | 2021-03-31 | −$8.8M | — | — | — |
| Q3 2020 | 2020-09-30 | −$7.6M | — | — | — |
Spruce Biosciences free cash flow growth trends
Over the last five reported fiscal years, free cash flow declined from −$12.6M to −$56.0M, a net decrease of $43.3M. Spruce Biosciences's latest reported quarter, Q2 2026, generated −$22.3M in free cash flow, a decrease of $10.0M year over year.
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Spruce Biosciences filings at SEC.gov ↗